Investigating the morphological, mechanical and degradation properties of scaffolds comprising collagen, gelatin and elastin for use in soft tissue engineering

Journal of the Mechanical Behavior of Biomedical Materials

Volumn 10, Issue , 2012, Pages 62-74

  Grover, Chloe N ^a   Cameron, Ruth E ^a   Best, Serena M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Collagen; Degradation; Elastin; Gelatin; Mechanical properties

Indexed keywords

ADHESION STUDIES; CARBODIIMIDES; CELL ATTACHMENTS; CELL BINDING; COLLAGEN-BASED SCAFFOLDS; DEGRADATION RESISTANCE; DEGRADATION TIME; DESIGN STRATEGIES; ECM COMPOSITION; ELASTIN; EXTRACELLULAR MATRICES; GELATIN; HT-1080 CELLS; INSOLUBLE ELASTIN; MATERIAL COST; POROUS STRUCTURES; SCAFFOLD STRUCTURES; SOFT TISSUE; SOFT TISSUE ENGINEERING; STRUCTURAL STABILITIES; TENSILE STIFFNESS; TISSUE REGENERATION;

BIOMECHANICS; CELL ADHESION; COLLAGEN; DEGRADATION; ELECTRON MICROSCOPY; GLYCOPROTEINS; MECHANICAL PROPERTIES; PHYSICAL PROPERTIES; STABILITY; STIFFNESS; TISSUE;

SCAFFOLDS (BIOLOGY);

COLLAGEN TYPE 1; ELASTIN; GELATIN; TISSUE SCAFFOLD;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL INFILTRATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; CROSS LINKING; DEGRADATION; HUMAN; HUMAN CELL; MECHANICS; MORPHOLOGY; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; PROTEIN INTERACTION; SOFT TISSUE; SWELLING; TENSILE STRENGTH; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN; COMPRESSIVE STRENGTH; COST-BENEFIT ANALYSIS; ELASTIN; EXTRACELLULAR MATRIX; GELATIN; HUMANS; MATERIALS TESTING; MECHANICAL PROCESSES; MODELS, MOLECULAR; PROTEIN CONFORMATION; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84859946459     PISSN: 17516161     EISSN: 18780180     Source Type: Journal    
DOI: 10.1016/j.jmbbm.2012.02.028     Document Type: Article

References (53)

1. Alter P.H., et al. B-type natriuretic peptide and wall stress in dilated human heart. Mol. Cell. BioChem. 2008, 314:179-191.
2. Bishop J.E.R., et al. Enhanced deposition of predominantly type I collagen in myocardial disease. J. Mol. Cell. Cardiol. 1990, 22:1157-1165.
3. Buttafoco L.B., et al. First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying. J. Biomed. Mater. Res. 2005, 77:357-368.
4. Charulatha V., Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003, 24:759-767.
5. Chiu L.L.Y., et al. Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol. Biosci. 2010, 10:1286-1301.
6. Chiu L.L.Y., Radisic M. Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31:226-241.
7. Daamen W.F., et al. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials 2003, 24:4001-4009.
8. Daamen W.F., et al. Elastin as a biomaterial for tissue engineering. Biomaterials 2007, 28:4378-4398.
9. Daamen W.F., et al. A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation without calcification. Tissue Eng. 2008, 14:349-359.
10. Davidenko N., et al. Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater. 2010, 6:3957-3968.
11. Debessa C.R.G., et al. Age related changes of the collagen network of the human heart. Mech. Ageing Dev. 2001, 122:1049-1058.
12. de Souza R.R. Aging of myocardial collagen. Biogerontology 2002, 3:325-335.
13. Elliott J.T., et al. Thin films of collagen affect smooth muscle cell morphology. Langmuir 2002, 19:1506-1514.
14. Engelmayr G.C.M., et al. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat. Mater. 2008, 7:1003-1010.
15. Fujimoto K.L.K., et al. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J. Am. Coll. Cardiol. 2007, 49:2292-2300.
16. Fung Y.C. Biomechanics: Mechanical Properties of Living Tissues 1993, Springer, US.
17. Gerdes A.M., et al. Regional differences in myocyte size in normal rat heart. Anat. Rec. 1986, 215:420-426.
18. Geutjes P.J., et al. From molecules to matrix: construction and evaluation of molecularly defined bioscaffolds. Tissue Eng. 2007, 585:279-295.
19. Gosline J.M., et al. Elastic proteins: biological roles and mechanical properties. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2002, 357:121-132.
20. Hafemann B., et al. Cross-linking by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) of a collagen/elastin membrane meant to be used as a dermal substitute: effects on physical, biochemical and biological features in vitro. J. Mater. Sci. Mater. Med. 2001, 12:437-446.
21. Harley B., et al. Mechanical characterization of collagen-glycosaminoglycan scaffolds. Acta Biomater. 2007, 3:463-474.
22. Hidalgo-Bastida L.A., et al. Cell adhesion and mechanical properties of a flexible scaffold for cardiac tissue engineering. Acta Biomater. 2007, 3:457-462.
23. Huang Y.S., et al. In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials 2005, 26:7616-7627.
24. Jorge-Herrero E.P., et al. Influence of different chemical cross-linking treatments on the properties of bovine pericardium and collagen. Biomaterials 1999, 20:539-545.
25. Kim B.S., Mooney D.J. Scaffolds for engineering smooth muscle under cyclic mechanical strain conditions. J. Biomech. Eng. 2000, 122:210-215.
26. Koshy S.K., et al. Collagen cross-linking: new dimension to cardiac remodeling. Cardiovasc. Res. 2003, 57:594-598.
27. Kozlov P.V., Burdygina G.I. The structure and properties of solid gelatin and the principles of their modification. Polymer 1983, 24:651-666.
28. Lee C.H., et al. Biomedical applications of collagen. Int. J. Pharm. 2001, 221:1-22.
29. Li R.K., et al. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:63-69.
30. Liu C., et al. Design and development of three-dimensional scaffolds for tissue engineering. Chem. Eng. Res. Des. 2007, 85:1051-1064.
31. Lowry, et al. The determination of collagen and elastin in tissues, with results obtained in various normal tissues from different species. J. Biol. Chem. 1941, 139:795-804.
32. Madhavan K., et al. Evaluation of composition and crosslinking effects on collagen-based composite constructs. Acta Biomater. 2010, 6:1413-1422.
33. Marijianowski M.M.H., et al. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. J. Am. Coll. Cardiol. 1995, 25:1263-1272.
34. Mukherjee D., Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J. Clin. Investig. 1991, 88:1141-1146.
35. Mukherjee D., Sen S. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure. J. Mol. Cell. Cardiol. 1993, 25:185-196.
36. Murphy C.M., et al. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31:461-466.
37. Nagueh S.F., et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 2004, 110:155-162.
38. Norton G.R., et al. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 1997, 96:1991-1998.
39. O'Brien F.J., et al. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005, 26:433-441.
40. Olde Damink L.H., et al. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 1996, 17:765-773.
41. Pauschinger, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99:2750-2756.
42. Pieper J.S., et al. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 1999, 20:847-858.
43. Radisic M., Vunjak-Novakovic G. Cardiac tissue engineering. J. Serb. Chem. Soc. 2005, 70:541-556.
44. Rosellini E., et al. Preparation and characterization of alginate/gelatin blend films for cardiac tissue engineering. J. Biomed. Mater. Res. 2009, 91:447-453.
45. van Luyn M.J., et al. Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 2002, 23:4793-4801.
46. Wang B.A., et al. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J. Biomed. Mater. Res. 2010, 94:1100-1110.
47. Website: Last accessed December 2012. Collagen type III price and availability. From: http://www.sigmaaldrich.com.
48. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 1989, 13:1637-1652.
49. Xiang Z.R., et al. Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue Eng. 2006, 12:2467-2478.
50. Yamamoto K.T., et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc. Res. 2002, 55:76-82.
51. Yang S.H., et al. Gelatin/chondroitin-6-sulfate copolymer scaffold for culturing human nucleus pulposus cells in vitro with production of extracellular matrix. J. Biomed. Mater. Res. 2005, 74:488-494.
52. Zhong L.Y., et al. Left ventricular regional wall curvedness and wall stress in patients with ischemic dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H573-H584.
53. Zimmermann W.H., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.